Checkpoint inhibition through small molecule-induced internalization of programmed death-ligand 1
Park, J.-J., Thi, E.P., Carpio, V.H. Checkpoint inhibition through small molecule-induced internalization of programmed death-ligand 1. Nat Commun. (2021). https://doi.org/10.1038/s41467-021-21410-1
Read more
Targeting macrophage checkpoint inhibitor SIRPα for anticancer therapy
Liu, J., Xavy, S., Mihardja, S. et al. Targeting macrophage checkpoint inhibitor SIRPα for anticancer therapy. JCI Insight. (2020). https://doi.org/10.1172/jci.insight.134728
Read more
Anticancer immunity induced by a synthetic tumor-targeted CD137 agonist
Upadhyaya, P., Lahdenranta, J., Hurov, K. et al. Anticancer immunity induced by a synthetic tumor-targeted CD137 agonist. J Immunother Cancer. (2021). http://dx.doi.org/10.1136/jitc-2020-001762
Read more
B7-H3×4-1BB bispecific antibody augments antitumor immunity by enhancing terminally differentiated CD8+ tumor-infiltrating lymphocytes
You, G., Lee, Y., Kang, Y.-W. et al. B7-H3×4-1BB bispecific antibody augments antitumor immunity by enhancing terminally differentiated CD8+ tumor-infiltrating lymphocytes. Sci Adv. (2021). DOI: 10.1126/sciadv.aax3160
Read more